ARTICLE | Discovery & Translation
BioCentury’s roundup of translational innovation also includes a new target for arrhythmia and four papers with links to newcos
By Danielle Golovin, Senior Biopharma Analyst
November 27, 2024 11:13 PM UTC
Collaborators from Medical University of South Carolina and University of Florida, including Tolerance Bio Inc. co-founder Holger Russ, reported a method to reduce immune-mediated rejection of beta cell replacement therapy.
The team edited human pluripotent stem cells to express an inert bait protein, a truncated version of EGFR, and engineered regulatory T cells (Tregs) to express a CAR that binds to the bait. …
- SEO Powered Content & PR Distribution. Get Amplified Today.
- PlatoData.Network Vertical Generative Ai. Empower Yourself. Access Here.
- PlatoAiStream. Web3 Intelligence. Knowledge Amplified. Access Here.
- PlatoESG. Carbon, CleanTech, Energy, Environment, Solar, Waste Management. Access Here.
- PlatoHealth. Biotech and Clinical Trials Intelligence. Access Here.
- Source: https://www.biocentury.com/article/654335/science-spotlight-reducing-immune-rejection-of-stem-cell-derived-therapies